Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
Go back to Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data| (NASDAQ: PALI) | Delayed: 1.41 -0.13 (8.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $ | |||
| Open | $1.55 | 52 Week Low | $ | |||
| Day High | $1.56 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $ | |||
| Volume | 3,889,614 | |||||



